Management of Venous Thromboembolism in France: a National Survey Among Vascular Medicine Physicians

Study Overview
=================
Brief Summary
-----------------
In France, venous thromboembolic (VTE) disease is usually managed by vascular medicine physicians (VMP). The national OPTIMEV study, conducted more than 12 years ago among VMP practicing in hospital and in the community described the management of VTE in routine clinical practice. Since then a large number of practice changing studies have been published. This includes trials that have validated the use of direct oral anticoagulants (DOAC), the new standard of care of VTE, as per new national and international guidelines. Management of VTE in 2019 appears to be significantly different from the one that prevailed more than 10 years ago when the last national survey was conducted. It is therefore important to have an update on the routine clinical practice management of VTE by VMP. In this perspective the investigators aim to conduct a national survey among VMP practicing in France

Official Title
-----------------
Management of Venous Thromboembolism in France: a National Survey Among Vascular Medicine Physicians

Conditions
-----------------
Survey, Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism, Anticoagulant

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: vascular medicine physicians who are active members of the SFMV (French Society of Vascular Medicine) vascular medicine physicians registered as willing to do medical research Exclusion Criteria: vascular medicine physicians who refuse to provide consent vascular medicine physicians who are retired non-practicing vascular medicine physicians

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| VMP members of the SFMV<br>VMP (vascular medicine physicians) members of the SFMV (French Society of Vascular Medicine ) | |
| VMP registered as willing to do medical research<br>VMP (vascular medicine physicians) registered as willing to do medical research | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Inter-practician variability of clinical care of venous thromboembolic in routine clinical practice | The variation in venous thromboembolic management in routine clinical practice is assessed by analysing the management of the 5 consecutive acute venous thromboembolic patients reported by each participating physician | up to 3 months after inclusion | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Inter-practician variability of clinical care of venous thromboembolic according to patient age | patient characteristics are : cancer, extreme body weight, severe renal impairment, elderly or pregnant patients, high bleeding risk | up to 6 months after inclusion | 
| Inter-practician variability of clinical care of venous thromboembolic according to patient body weight | patient characteristics are : cancer, extreme body weight, severe renal impairment, elderly or pregnant patients, high bleeding risk | up to 6 months after inclusion | 
| Inter-practician variability of clinical care of venous thromboembolic according to patient bleeding risk | patient characteristics are : cancer, extreme body weight, severe renal impairment, elderly or pregnant patients, high bleeding risk | up to 6 months after inclusion | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Survey, Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism, Anticoagulant, Clinical Practice, Therapeutic management